![Thomas Kotarakos](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thomas Kotarakos
Directeur Financier/CFO chez
PARABILIS MEDICINES, INC.
Fortune : - $ au 31/05/2026
Profil
Thomas Kotarakos is Chief Financial Officer at Parabilis Medicines, Inc. starting in 2026.
Formerly, Mr. Kotarakos was Controller at Seres Therapeutics, Inc. from 2014 to 2018 and Senior VP-Finance & Business Operations at Codiak BioSciences, Inc. from 2018 to 2021.
Education includes undergraduate and graduate degrees from Bentley University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 10/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Thomas Kotarakos
| Sociétés | Poste | Début |
|---|---|---|
| PARABILIS MEDICINES, INC. | Directeur Financier/CFO | 10/12/2021 |
Anciens postes connus de Thomas Kotarakos
| Sociétés | Poste | Fin |
|---|---|---|
| CODIAK BIOSCIENCES | Corporate Officer/Principal | 01/12/2021 |
| SERES THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 01/10/2018 |
Formation de Thomas Kotarakos
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
24
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Bentley University
 Bentley University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Seres Therapeutics, Inc.
 Seres Therapeutics, Inc. BiotechnologyHealth Technology Develops novel treatments for diseases related to the human microbiome | Health Technology |
Parabilis Medicines
 Parabilis Medicines Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops medicines for cancers and tumors | Health Technology |
Codiak BioSciences, Inc.
 Codiak BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops exosome based therapeutics | Health Technology |
Choisissez Zonebourse 
